BIB provides 2x daily exposure to a modified market-cap-weighted index of biotechnology and pharmaceutical companies listed on NASDAQ.
The ProShares Trust ProShares Ultra Nasdaq Biotechnology (BIB) ETF price today is $88.17. The ETF currently has a market capitalization of $91.70M, with a daily trading volume of $9.55K shares.
For investors analyzing ETF performance, ProShares Trust ProShares Ultra Nasdaq Biotechnology has traded within a daily range of $87.11 - $88.17, with the previous close at $86.03. This data provides insight into recent price fluctuations and liquidity.
Ready to get started? Follow the steps below, or read our guide on how to buy ProShares Ultra Nasdaq Biotechnology 2X Shares stock on Kraken starting from $10.
Create an account
Open the Kraken app to confirm your eligibility and follow the steps for account verification.
Deposit funds
Once your account has been verified and stock trading is unlocked, you can deposit funds into your account using your preferred payment method.
Buy BIB
Search for BIB in the Kraken app, enter the amount you want to invest, review the important details and tap Confirm to place an order to buy BIB.
Explore the most-traded stocks today
NVDA
ENSC
ONMD
NFLX
Browse today’s biggest stock market winners
PTLE
VCIG
IXHL
SOLT
Compare the worst-performing stocks of the day
Currently available in the U.S. only; may not be available in all states. Brokerage services are provided by Kraken Securities LLC, member FINRA/SIPC. Please view the firm’s profile, registration and background of our registered reps on https://brokercheck.finra.org/. Digital asset services offered by Payward Interactive, not a member of FINRA/ SIPC and not FDIC insured. This is not an offer, solicitation, inducement or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Kraken Securities is not registered. All trading involves risk, including loss of your investments. View full disclosures at: Equities Disclosures and Crypto Risk Disclosures.
Leveraged and inverse ETFs typically are designed to achieve their stated performance objectives on a daily basis, but investors should be aware that performance of these ETFs over a period longer than one day can differ significantly from their stated daily performance objectives. Investors considering ETFs should evaluate each investment closely and not assume all ETFs are alike. Leveraged ETFs seek to deliver multiples of the performance of the index or benchmark it tracks. Inverse ETFs (also called “short” funds) seek to deliver the opposite of the performance of the index or benchmark it tracks. See the full disclaimer HERE.
*Other applicable fees may apply.
